Carrie M. Margulies, et al. Efficient Targeted Integration in Human T Cells with CRISPR-Cas9 for the Treatment of X-Linked Hyper-IgM Syndrome. Presented at the American Society of Gene & Cell Therapy (ASGCT) 21st Annual Meeting, May 16 – 19.

Apr

22

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting

Feb

28

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates

Feb

21

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events